Reviewing a patient’s potential risk for osteoporosis should be a routine part of each visit for patients with IBD.
C. Andrew Kistler, MD, PharmD
Andy authors Cancer Therapy Advisor's "In the Clinic" column. He is a gastroenterologist with interests in GI oncology, immunotherapy, the gut microbiome, and clinical pharmacology.
